These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 5475304)
1. Therapeutic orphans: who speaks for children? Shirkey HC South Med J; 1970 Nov; 63(11):1361-3. PubMed ID: 5475304 [No Abstract] [Full Text] [Related]
2. New pediatric dosage rules: information and testing. Feeg VD Pediatr Nurs; 1998; 24(6):518, 613. PubMed ID: 10085992 [No Abstract] [Full Text] [Related]
3. FDA problems with medications in the marketplace: III. 'Therapeutic orphans'. Archambault GF Hosp Formul; 1976 Dec; 11(12):690. PubMed ID: 1028797 [No Abstract] [Full Text] [Related]
5. Off-label or off-limits? Ritchey ML J Urol; 2013 Jul; 190(1):8-9. PubMed ID: 23608037 [No Abstract] [Full Text] [Related]
6. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products. Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700 [No Abstract] [Full Text] [Related]
7. Deterring the importation of counterfeit pharmaceutical products. Stearn DW Food Drug Law J; 2004; 59(4):537-61. PubMed ID: 15875351 [No Abstract] [Full Text] [Related]
8. Drugs and biologics in pregnancy and breastfeeding: FDA in the 21st century. Kweder SL Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):605-9. PubMed ID: 18704917 [No Abstract] [Full Text] [Related]
9. Characteristics of container labeling in a sample of commonly prescribed children's oral medications. Wallace LS; Keenum AJ; DeVoe JE Res Social Adm Pharm; 2010 Dec; 6(4):272-9. PubMed ID: 21111385 [TBL] [Abstract][Full Text] [Related]
10. New classification of drugs. J Fla Med Assoc; 1972 Jan; 59(1):37. PubMed ID: 5058956 [No Abstract] [Full Text] [Related]
11. Improving pediatric dosing through pediatric initiatives: what we have learned. Rodriguez W; Selen A; Avant D; Chaurasia C; Crescenzi T; Gieser G; Di Giacinto J; Huang SM; Lee P; Mathis L; Murphy D; Murphy S; Roberts R; Sachs HC; Suarez S; Tandon V; Uppoor RS Pediatrics; 2008 Mar; 121(3):530-9. PubMed ID: 18310202 [TBL] [Abstract][Full Text] [Related]
12. FDA labeling status of pediatric medications. Yoon EY; Davis MM; El-Essawi H; Cabana MD Clin Pediatr (Phila); 2006; 45(1):75-7. PubMed ID: 16429220 [No Abstract] [Full Text] [Related]
13. F.D.A. to assess O.T.C. drugs for safety, efficacy, labeling. Bowles GC Mod Hosp; 1972 Mar; 118(3):126. PubMed ID: 5058060 [No Abstract] [Full Text] [Related]
14. The concept of drug expiration dating. Wollish EG Bull Parenter Drug Assoc; 1969; 23(1):48-52. PubMed ID: 5765721 [No Abstract] [Full Text] [Related]
16. Color coding of multisource products should be standardized or eliminated. Clifton GD; Record KE Am J Hosp Pharm; 1988 May; 45(5):1066. PubMed ID: 3400647 [No Abstract] [Full Text] [Related]
17. Improving drug quality through certification experience. Weiss PJ Am J Pharm Sci Support Public Health; 1974; 146(3):86-90. PubMed ID: 4852375 [No Abstract] [Full Text] [Related]
19. The federal preemption debate in pharmaceutical labeling product liability actions. Gross JM; Curry JA Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866 [No Abstract] [Full Text] [Related]
20. Drug reactions: the role of the package insert. Barnett FJ J Leg Med (N Y); 1973; 1(1):19-23. PubMed ID: 4548069 [No Abstract] [Full Text] [Related] [Next] [New Search]